Monoclonal Antibodies
According to a recent randomized controlled trial, rituximab increased the duration of remission
The results of a pair of long-term survival studies indicate the therapeutic value of
Biopharmaceutical company MorphoSys is reporting that it has been given fast track
The drug Rituximab is showing to slow symptoms of lymphoma, but does it increase survival:
According to findings to be reported at the annual meeting of the American Society of Clinical
Pharmaceutical giant Pfizer is withdrawing the monoclonal antibody
Today the US Food and Drug Administration granted accelerated approval for Darzalex (
At the 17th Congress of the European Hematology Association (EHA), biopharmaceutical company
According to research presented at the annual meeting of the American Society of Hematology,
In case you're unfamiliar, the Rituxan Retirement Plan (RRP) is an inside joke amongst
Spectrum Pharmaceuticals is launching a new patient campaign surrounding the company's lead
Spectrum Pharmaceuticals Inc, the biotech firm that owns and makes the
The US Food and Drug Administration has approved the use of the anti-CD20 monoclonal antibody